AI Transforms Healthcare and Life Sciences Industry
Artificial intelligence is reshaping healthcare. It is no longer a future concept — it is a present-day driver of clinical outcomes and business growth. AI is accelerating radiology, drug discovery, medical device manufacturing, and treatment innovation. Digital twins of the human body are now a reality.
NVIDIA‘s second annual State of AI in Healthcare and Life Sciences survey captures this shift. The industry has moved from AI experimentation to full-scale execution. Measurable return on investment (ROI) is now emerging across core applications.
AI Adoption Ramps Up Across Healthcare
AI adoption has grown across every healthcare segment. 70% of respondents said their organizations are actively using AI. That is up from 63% in 2024. Growth spans digital healthcare, pharma, biotech, payers, providers, and medical technology.
Digital healthcare leads adoption at 78%. Medical technology follows at 74%. This rise signals that AI is no longer limited to early adopters. It is becoming a baseline operational expectation.
Adoption Driven by Real Clinical Needs
The greatest impact comes from embedding AI into existing workflows. Treating it as a separate layer limits results. Dr. Annabelle Painter, Clinical AI Strategy Lead at Visiba UK, puts it clearly: “Scaling generative AI in healthcare starts with focusing on real clinical and operational problems, rather than the technology itself.”
Institutions are prioritizing practical, measurable use cases. Technology-first strategies are giving way to outcome-first thinking.
Generative AI and Agentic AI Lead Workloads
69% of respondents are using generative AI and large language models (LLMs). That is up from 54% the previous year. Data analytics and predictive analytics followed as the next most-used workloads.
Agentic AI is new to this year’s survey. It ranked fourth overall. 47% of respondents are currently using or assessing AI agents. These agents support knowledge retrieval, research analysis, and workflow automation. Their rapid rise reflects growing confidence in autonomous AI systems.
Segment-Specific Use Cases
AI use cases align closely with each segment’s core functions. 61% of medical technology respondents use AI for medical imaging. This helps radiologists work faster and more accurately. 57% of pharmaceutical and biotechnology respondents identified drug discovery as a primary AI application.
Across the full industry, the top use cases were clinical decision support, medical imaging, and workflow optimization. Each delivers direct, measurable improvements in care quality and efficiency.
AI Budgets Grow With Strong ROI
The financial case for healthcare AI is clear. 85% of executives said AI is helping increase revenue. 80% said it is helping reduce costs. AI is also improving back-office productivity, patient interaction, and administrative automation.
ROI results vary by segment. 57% of medical technology respondents are seeing returns from AI-powered medical imaging. 46% of pharma and biotech respondents cited drug discovery as a top ROI use case. For digital healthcare providers, virtual health assistants led ROI at 37%. Among payers and providers, 39% pointed to administrative workflow optimization.
Budgets Set to Rise Significantly
Demonstrated value is driving investment. 85% of respondents said their AI budgets will increase this year. 46% expect increases of more than 10%. Only 12% expect budgets to stay flat.
Dr. Painter stresses the need for structured evaluation alongside spending: “Healthcare organizations that successfully integrate AI are those that explicitly fund and prioritize evaluation as a core operational function.”
Open Source Fuels Domain-Specific AI
Healthcare has broadly embraced open source AI tools. 82% of respondents said open source solutions are moderately to extremely important to their AI strategy. These frameworks allow organizations to build customized, domain-specific applications. They offer greater flexibility, transparency, and cost efficiency.
Balancing Openness With Accountability
Open source brings opportunity — but also responsibility. John Nosta, President of NostaLab, frames it well: “Open models are essential for exploration and for keeping the field honest. But in clinical environments, proprietary systems remain necessary for validation, integration, and trust.”
Discovery will be open. Deployment will demand stewardship. That balance is becoming the standard model for responsible AI adoption in healthcare.
The Road Ahead for Healthcare AI
The next 12 to 18 months will bring visible AI impact in logistics and administration. Scheduling, documentation, coding, and care coordination are already seeing steep adoption curves. Results in these areas are measurable now.
AI is maturing beyond pilot projects. Healthcare organizations are building infrastructure, governance frameworks, and cultural readiness. Clinical and commercial outcomes are improving together. The foundation for long-term AI transformation is firmly in place.
